Compare Immunovant Inc. Common Stock (IMVT) vs Carparts.Com Inc (PRTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Immunovant Inc. Common Stock vs Carparts.Com Inc — how do they compare? Immunovant Inc. Common Stock trades at $30.01 (market cap $6.62B), while Carparts.Com Inc trades at $8.59 (market cap $67.00M). The key difference: Immunovant Inc. Common Stock is far larger — about 98.8× Carparts.Com Inc's market cap, and Carparts.Com Inc is trading nearer its 52-week high, Immunovant Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Immunovant Inc. Common Stock for 0 Days and Carparts.Com Inc for 45 Days on average.
| IMVT | PRTS | |
|---|---|---|
Market Cap | $6.62B | $67.00M |
Volume | 1,131,364 | 50,584 |
Sector | Health | Consumer Cyclical |
52-Week High | $44.96 | $10.00 |
52-Week Low | $17.03 | $3.88 |
Typical Hold Time | 0 Days | 45 Days |
Enterprise Value | $5.72B | $79.96M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
CarParts.com (PRTS) trades at $8.59, down 0.23% with a bullish technical outlook. The company shows improving quarterly earnings beats but faces fundamental challenges with negative profitability metrics. Recent news highlights the company's focus on leveraging proprietary data as a competitive advantage. Technical indicators show strong moving average support while oscillators remain neutral.
The stock presents a mixed picture with strong analyst support (60% buy ratings) but persistent negative earnings. Investment opportunity lies in continued operational improvements and data-driven strategy execution, while risks include sustained negative cash flow and competitive pressures in the auto parts e-commerce sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Immunovant Inc. Common Stock
Immunovant is a clinical-stage immunology company developing therapies for autoimmune diseases. Its pipeline includes anti-FcRn antibody candidates designed for subcutaneous administration.
Read more on IMVT →About Carparts.Com Inc
CarParts.com Inc is an online provider of automotive aftermarket parts and repair information. The company principally sells its products to individual consumers through its network of websites and online marketplaces. The company's products consist of collision parts serving the body repair market, engine parts to serve the replacement parts market, and performance parts and accessories.
Read more on PRTS →
